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Abstract
We describe the prevalence of doctor-diagnosed arthritis 
and its impact on activities, work, and joint pain for 6 racial/
ethnic groups: non-Hispanic whites, non-Hispanic blacks, 
Hispanics, American Indians/Alaska Natives, Asians and 
Pacific Islanders, and multiracial or “other” respondents. 
We combined data from the 2002, 2003, and 2006 National 
Health Interview Survey (n = 85,784) and, after adjust-
ing for age, sex, and body mass index, compared racial/ 
ethnic  differences.  Arthritis-attributable  activity  limita-
tion, arthritis-attributable work limitation, and severe joint 
pain were higher for non-Hispanic blacks, Hispanics, and 
multiracial or other respondents with arthritis compared 
with non-Hispanic whites with arthritis. Our finding that 
arthritis  disproportionately  affects  certain  racial/ethnic 
minorities may be useful for planning interventions.
Objective
Arthritis affects 1 in 5 adults and is the most common 
cause of disability in the United States (1,2). It interferes 
with work and daily activities (3) and complicates the man-
agement of other chronic diseases (4,5). The prevalence and 
impact of arthritis (3,6) have been explored for large racial/
ethnic groups (non-Hispanic blacks and whites, Hispanics, 
and  non-Hispanic  “other”  races)  but  not  among  smaller 
non-Hispanic groups, which is necessary to tailor arthri-
tis  interventions  appropriately.  We  update  and  expand 
estimates of the prevalence of arthritis and its impact on 
activities, work, and joint pain for 6 racial/ethnic groups.
Methods
We  combined  data  from  the  2002,  2003,  and  2006 
National Health Interview Survey (NHIS), an in-person 
nationally representative survey of the US civilian, nonin-
stitutionalized population aged 18 years or older. We did 
not include NHIS data for 2004 and 2005 because arthri-
tis-attributable work limitation and joint pain were not 
assessed  in  those  years.  Doctor-diagnosed  arthritis  was 
defined as answering yes to the question, “Have you ever 
been told by a doctor or other health professional that you 
have some form of arthritis, rheumatoid arthritis, gout, 
lupus, or fibromyalgia?” Among respondents with arthri-
tis, arthritis-attributable activity limitation was defined 
as answering yes to the question, “Are you now limited in 
any way in any of your usual activities because of arthritis 
or joint symptoms?” For adults aged 18 to 64 years, arthri-
tis-attributable  work  limitation  was  defined  as  answer-
ing yes to the question, “Do arthritis or joint symptoms 
now affect whether you work, the type of work you do, or 
the amount of work you do?” Respondents were asked to 
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assess their joint pain in the past 30 days, on average, on 
a scale of 0 to 10, “where 0 is no pain or aching and 10 
is pain or aching as bad as it can be.” Severe joint pain 
was defined as 7 to 10. We present weighted estimates 
for  non-Hispanic  whites  (“whites”),  non-Hispanic  blacks 
(“blacks”),  Hispanics,  American  Indians/Alaska  Natives 
(AI/AN), Asians and Pacific Islanders (API), and multira-
cial or “other” respondents (MRO). People who reported 
their ethnicity as Hispanic were not further classified by 
race in this study. We calculated crude and age-adjusted 
prevalence estimates, odds ratios with logistic regression, 
and 95% confidence intervals by using SUDAAN, version 
10.0 (RTI International, Research Triangle Park, North 
Carolina) to account for the multistage probability sample. 
We age-adjusted estimates to the 2000 US population (7). 
We used t tests for differences in proportions and Wald F 
tests for differences in odds ratios. Differences were con-
sidered significant at P < .05.
Results
The sample size was 85,784, a mean response rate of 74%. 
The annualized prevalence of doctor-diagnosed arthritis 
was 21% (Table 1). The estimated unadjusted prevalence 
and weighted population for each group was whites, 24% 
(36 million); blacks, 19% (4.6 million); Hispanics, 11% (2.9 
million);  AI/AN,  25%  (280,000);  API,  8%  (667,000);  and 
MRO,  21%  (469,000).  Arthritis  prevalence  was  signifi-
cantly higher among respondents aged 45 years or older, 
women,  obese  respondents,  and  respondents  with  less 
education (Table 1). 
Of adults who reported arthritis, 38% reported activity 
limitation, 31% (of respondents aged 18-64 years) reported   
work limitation, and 26% reported severe joint pain dur-
ing the preceding 30 days (Table 2). Differences in these 
prevalences  were  observed  among  the  6  racial/ethnic 
groups. The prevalence of arthritis was significantly lower 
among Hispanics and API than among whites and signifi-
cantly higher among AI/AN. The prevalences of activity 
limitation,  work  limitation,  and  severe  joint  pain  were 
significantly higher among blacks, Hispanics, and MRO 
than among whites.
Results  of  logistic  regression  analyses  indicate  that 
after  adjusting  for  age,  sex,  and  body  mass  index,  API, 
Hispanics,  and  blacks  were  less  likely  and  AI/AN  were 
more likely than whites to have arthritis (Figure). Blacks 
and Hispanics were approximately 1.3 times as likely as 
whites to have activity limitation, 1.8 to 1.9 times as likely 
to have severe joint pain, and 1.6 to 1.7 times as likely to 
have  work  limitation.  MRO  were  1.7  times  as  likely  as 
whites to report activity limitation, 1.9 times as likely to 
report severe joint pain, and 2.2 times as likely to report   
work limitation. Differences between whites and AI/AN and 
between whites and API for all 3 impact measures were not 
significant, although statistical power was limited by small 
sample sizes.
 
Figure. Odds of having arthritis and associated limitations, by race/ethnic-
ity, National Health Interview Survey, United States, 2002, 2003, and 2006. 
Odds ratios were adjusted for age, sex, and body mass index. The horizontal 
lines indicate confidence intervals. Abbreviations: NHW, non-Hispanic white; 
NHB, non-Hispanic black; HIS, Hispanic; AI/AN, American Indian/Alaska Native; 
API, Asian/Pacific Islander; MRO, multiracial or “other.” Data for other and 
multiple race populations are combined. Respondents in this category were 
non-Hispanic. Arthritis was defined as answer of yes to the question, “Have you 
ever been told by a doctor or other health professional that you have some form 
of arthritis, rheumatoid arthritis, gout, lupus, or fibromyalgia?” Arthritis-attribut-
able activity limitation was defined as answer of yes to the question, “Are you 
now limited in any way in any of your usual activities because of arthritis or 
joint symptoms?” Severe joint pain was defined as a rating of 7-10 on a scale 
assessing average pain in the last 30 days, with 0 being no pain and 10 being 
worst pain. (Approximately 28% of respondents with doctor-diagnosed arthritis 
did not report joint pain in the past 30 days and were not asked the question 
about pain severity. For this analysis, these respondents were classified as not 
having severe joint pain and were included in the denominator.) Arthritis-attribut-
able work limitation was defined as answer of yes to the question, “Do arthritis 
or joint symptoms now affect whether you work, the type of work you do, or the 
amount of work you do?” among working-age respondents (18-64 years).
Discussion
Arthritis affects some racial/ethnic populations dispropor-
tionately. For example, the prevalence of arthritis is lower 
among blacks and Hispanics than among whites, but impact 
is worse. We generated estimates for smaller racial/ethnic 
groups that had been combined in a “non-Hispanic other” 
category  previously  (3).  Separating  these  groups  reveals VOLUME 7: NO. 3
MAY 2010
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differences such as a higher prevalence of arthritis among 
AI/AN and MRO compared with whites and API. Our find-
ings can be used to develop effective and culturally sensitive 
interventions that can be tailored to these populations.
Reasons for racial/ethnic differences are unknown and 
merit further investigation. They may be related to health 
care access, use of health care services, language barriers 
(8), differences in the prevalence of risk factors for arthri-
tis and related disability (eg, obesity, physically demand-
ing jobs), and cultural differences in the understanding 
of survey questions, willingness to report limitation and 
pain, and variations in patterns of medication use and self-
management approaches to manage pain.
Our  findings  are  subject  to  the  following  limitations:   
1) arthritis was self-reported and unconfirmed by a doc-
tor, although the case-finding question appears to be valid 
for  surveillance  purposes  (9);  2)  Hispanics  and  blacks 
report less access to health care than do whites and may 
be less likely to be diagnosed with arthritis, resulting in 
an underestimate of the prevalence of arthritis in these 
populations (10); and 3) the small number of AI/AN, API, 
and MRO in the sample limited our ability to precisely 
estimate the impact of arthritis. However, all estimates 
meet data quality standards set for the NHIS (<30% rela-
tive standard error). The results for the MRO group should 
be interpreted with caution, because it is a heterogeneous 
group.  Strengths  of  the  study  include  its  large  sample 
size, impact measures important to people with arthritis 
(eg, pain severity), and data to classify respondents into 
multiple race and ethnicity categories.
The US population is becoming more diverse. As data 
accumulate  on  the  racial/ethnic  differences  in  arthri-
tis  prevalence  and  impact,  we  need  to  develop  cultur-
ally  appropriate  interventions  for  the  populations  most 
affected.  Evidence-based  public  health  interventions 
that  improve  pain  and  functional  limitations  reach  few 
adults with arthritis (11). Future efforts to increase reach 
should  use  appropriately  tailored  interventions  such  as 
the  Spanish-language  health  communication  campaign 
Buenos Dias Artritis (12).
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Tables
Table 1. Prevalence of Arthritis Among Adults,a by Race/Ethnicity, National Health Interview Survey, United States, 2002, 
2003, and 2006
Characteristic
Total, % (95% 
CI) 
N = 85,784
Whiteb, % (95% 
CI) 
n = 54,493
Blackb, % (95% 
CI) 
n = 12,063
Hispanic, % 
(95% CI) 
n = 14,880
AI/AN, % (95% 
CI) 
n = 391
API, % (95% CI) 
n = 3,009
MROc, % (95% 
CI) 
n = 948
Overall prevalence
Unadjusted 21.2 (20.8-21.6) 23.8 (23.4-24.3) 19.4 (18.5-20.4) 11.1 (10.5-11.8) 25.2 (20.8-30.2) 8.4 (7.2-9.8) 20.7 (17.7-24.0)
Adjustedd 21.1 (20.7-21.4) 22.3 (21.9-22.7) 21.8 (21.0-22.7) 15.6 (14.7-16.4) 28.6 (24.5-33.1) 10.6 (9.2-12.2) 23.6 (20.7-26.7)
Prevalence by subgroup
Age, y
18-44 7.5 (7.2-7.9) 8.9 (8.5-9.4) 6.7 (6.0-7.5) 3.6 (3.1-4.0) 14.5 (9.1-22.4) 2.2 (1.6-2.9) 10.4 (7.9-13.5)
45-64 29.2 (28.6-29.9) 30.6 (29.9-31.4) 30.3 (28.6-32.0) 22.0 (20.3-23.9) 38.1 (30.1-46.7) 12.0 (9.6-15.0) 33.5 (27.2-40.4)
≥65 48.8 (47.8-49.7) 49.2 (48.1-50.3) 54.0 (51.5-56.4) 41.6 (38.4-44.8) 55.6 (38.4-71.5) 34.6 (28.4-41.3) 47.5 (38.4-56.7)
Sex
Men 17.4 (16.9-17.9) 20.2 (19.6-20.8) 14.0 (12.8-15.3) 7.7 (7.0-8.5) 22.3 (15.7-30.6) 6.7 (5.3-8.3) 14.5 (11.3-18.4)
Women 24.7 (24.2-25.2) 27.2 (26.6-27.9) 23.8 (22.7-25.0) 14.6 (13.7-15.6) 28.0 (20.6-36.9) 10.1 (8.2-12.3) 26.2 (22.1-30.8)
Body mass index
<25.0 kg/m2 15.9 (15.4-16.4) 18.1 (17.5-18.8) 13.5 (12.3-14.7) 7.0 (6.2-7.8) 16.3 (10.1-25.1) 7.0 (5.8-8.6) 15.4 (11.4-20.5)
25.0-29.9 
kg/m2
21.1 (20.5-21.7) 24.0 (23.3-24.7) 16.8 (15.4-18.4) 11.4 (10.4-12.5) 28.8 (20.4-39.1) 9.9 (7.6-12.7) 15.5 (11.6-20.3)
≥30.0 kg/m2 30.5 (29.7-31.3) 33.9 (32.8-34.9) 27.2 (25.5–29.0) 17.2 (15.8-18.7) 30.4 (23.4-38.5) 17.7 (11.9-25.4) 33.2 (26.8-40.3)
Education
Less than high 
school
25.2 (24.3-26.2) 31.7 (30.3-33.1) 31.6 (29.5-33.9) 12.2 (11.3-13.2) 27.2 (17.2-40.1) 17.4 (12.9-23.0) 25.4 (18.2-34.1)
High school 
diploma
23.2 (22.6-23.9) 26.3 (25.5-27.1) 18.2 (16.8-19.6) 10.6 (9.4-11.8) 21.2 (13.9-31.0) 8.5 (5.8-12.2) 18.3 (13.2-24.7)
More than high 
school
18.9 (18.5-19.4) 21.0 (20.4-21.6) 14.9 (13.7-16.1) 10.2 (9.1.-11.4) 26.9 (20.0-35.2) 6.6 (5.4-8.0) 20.8 (17.0-25.1)
 
Abbreviations: CI, confidence interval; AI/AN, American Indian/Alaska Native; API, Asian/Pacific Islander; MRO, multiracial or other. 
a Answer of yes to the question, “Have you ever been told by a doctor or other health professional that you have some form of arthritis, rheumatoid arthritis, 
gout, lupus, or fibromyalgia?” 
b Non-Hispanic. 
c Data for “other” and multiple race populations are combined. Respondents in this category were non-Hispanic. 
d Adjusted for age with the 2000 census projected population (7).VOLUME 7: NO. 3
MAY 2010
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Table 2. Proportion of Adults With Arthritisa Who Have Arthritis-Attributable Activity Limitation, Severe Joint Pain, or Arthritis-
Attributable Work Limitation, by Race/Ethnicity, National Health Interview Survey, United States, 2002, 2003, and 2006
Characteristic
Total, % (95% 
CI) 
N = 85,784
Whiteb, % (95% 
CI) 
n = 54,493
Blackb, % (95% 
CI) 
n = 12,063
Hispanic, % 
(95% CI) 
n = 14,880
AI/AN, % (95% 
CI) 
n = 391
API, % (95% CI) 
n = 3,009
MROc, % (95% 
CI) 
n = 948
Activity limitationd
Unadjusted 37.7 (36.9-38.6) 36.2 (35.2-37.3) 44.6 (42.6-46.7) 43.2 (40.2-46.3) 39.1 (29.0-50.2) 38.2 (31.8-45.1) 49.5 (41.8-57.2)
Adjustede 35.8 (34.8-36.9) 34.3 (33.0–
35.6)
43.3 (40.4-46.2) 41.7 (37.9-45.5) 31.6 (24.1-40.2) 32.2 (24.7-40.8) 47.6 (39.1-56.1)
Severe joint painf
Unadjusted 25.6 (24.9-26.4) 23.1 (22.3-24.0) 38.3 (36.0-40.5) 36.4 (33.8-39.1) 28.7 (21.9-36.6) 18.5 (13.4-25.0) 36.6 (29.7-44.1)
Adjusted 25.4 (24.3-26.5) 23.0 (21.8-24.3) 36.7 (33.8-39.8) 35.5 (32.1-39.0) 26.5 (20.0-34.2) 17.8 (12.3-25.0) 33.7 (26.5-41.8)
Work limitationg
Unadjusted 31.2 (30.2-32.3) 28.8 (27.6-30.0) 41.6 (38.9-44.4) 39.7 (36.4-43.1) 37.7 (27.3-49.4) 28.2 (19.9-38.2) 46.4 (37.6-55.4)
Adjusted 30.8 (29.6-32.1) 28.6 (27.1-30.2) 40.8 (37.3-44.3) 38.7 (34.9-42.7) 30.2 (21.9-40.0) 27.0 (18.4-37.9) 42.7 (33.4-52.6)
 
Abbreviations: CI, confidence interval; AI/AN, American Indian/Alaska Native; API, Asian/Pacific Islander; MRO, multiracial or other. 
a Answer of yes to the question, “Have you ever been told by a doctor or other health professional that you have some form of arthritis, rheumatoid arthritis, 
gout, lupus, or fibromyalgia?” 
b Non-Hispanic. 
c Data for “other” and multiple race populations are combined. Respondents in this category were non-Hispanic. 
d Answer of yes to the question, “Are you now limited in any way in any of your usual activities because of arthritis or joint symptoms?” 
e Adjusted for age with the 2000 census projected population (7). 
f Rating of 7-10 on a scale assessing average pain in the last 30 days, with 0 being no pain and 10 being worst pain. (Approximately 28% of respondents with 
doctor-diagnosed arthritis did not report joint pain in the past 30 days and were not asked the question about pain severity. For this analysis, these respon-
dents were classified as not having severe joint pain and were included in the denominator.) 
g Among working-age respondents (18-64 years), answer of yes to the question, “Do arthritis or joint symptoms now affect whether you work, the type of work 
you do, or the amount of work you do?”